DNL343 |
DNL343 : Activator of EIF2B2
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| EIF2B2 |
|
Activator
10 nM - 3 µM
Selectivity
In Vitro Selectivity Assessment
Potency Assay Off-Target:
CEREP and kinase panel assays
Selectivity Assessment Description:
No significant hits in CEREP and Kinase assay panels
Potency Cellular
In Vitro
EIF2B2
Mode of Action: Activator
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/acs.jmedchem.3c02422
In Vivo Validations
Rat
Dose: 1 mg/kg
Route of delivery:
Intravenous
Plasma half life:
12.5 hr
Systemic clearance:
0.4 mL/min/kg
Bioavailability:
65% (3 mg/kg PO dose)
Volume of Distribution at Steady-State:
0.31 L/kg
DOI Reference: 10.1021/acs.jmedchem.3c02422
Dog
Dose: 0.5 mg/kg
Route of delivery:
Intravenous
Plasma half life:
7.4 hr
Systemic clearance:
4.8 mL/min/kg
Bioavailability:
>99% (1 mg/kg PO dose)
Volume of Distribution at Steady-State:
2.7 L/kg
DOI Reference: 10.1021/acs.jmedchem.3c02422
Monkey (Cynomolgus)
Dose: 0.5 mg/kg
Route of delivery:
Intravenous
Plasma half life:
7.6 hr
Systemic clearance:
2.9 mL/min/kg
Bioavailability:
>99% (1 mg/kg PO dose)
Volume of Distribution at Steady-State:
1.9 L/kg
DOI Reference: 10.1021/acs.jmedchem.3c02422
Chemical Information
| Molecular Formula | C20H19ClF3N3O4 |
| SMILEs | O=C(COc1ccc(Cl)cc1)NC12CC(c3nnc(C4CC(OC(F)(F)F)C4)o3)(C1)C2 |
| InChI | InChI=1S/C20H19ClF3N3O4/c21-12-1-3-13(4-2-12)29-7-15(28)25-19-8-18(9-19,10-19)17-27-26-16(30-17)11-5-14(6-11)31-20(22,23)24/h1-4,11,14H,5-10H2,(H,25,28) |
| Molecular weight | 457.10 Da |
| AlogP | 0.0 |
| HBond acceptors | 7 |
| HBond donors | 1 |
| Atoms | 50 |
References
Publications
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.